Concepedia

Mercedes Lobera

ML

Statistics

Publications

16

Citations

2.6K

H-Index

14

Active since

2003

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Harvard University

Brandeis University

Brigham and Women's Hospital

Mercedes Lobera is an author at GlaxoSmithKline (United States) specializing in medicinal chemistry, immunology, and life sciences.

ORCID

Publications per year

2003–2018

16

Publications

16

Individual intestinal symbionts induce a distinct population of RORγ <sup>+</sup> regulatory T cells

Esen Sefik, Naama Geva‐Zatorsky, Sungwhan F. Oh et al. · Science · 2015 · 879 citations · Full text

, , +17

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Jennifer L. Guerriero, Alaba Sotayo, Holly Ponichtera et al. · Nature · 2017 · 551 citations · Full text

, , +12

Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group

Mercedes Lobera, Kevin P. Madauss, Denise Teotico Pohlhaus et al. · Nature Chemical Biology · 2013 · 375 citations

, , +12

Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms

Sheng Xiao, Nir Yosef, Jianfei Yang et al. · Immunity · 2014 · 280 citations · Full text

, , +14

Pharmacologic Inhibition of RORγt Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo

Jill Skepner, Radha Ramesh, Mark Trocha et al. · The Journal of Immunology · 2014 · 136 citations

, , +17

1–5 of 16